Brief: Evotec Says Joins Nurture-Aki Consortium To Gain Multi-Omics-Based Molecular Understanding Of Acute Kidney Injury
June 25 (Reuters) - EVOTEC SE EVTG.DE: JOINS NURTURE-AKI CONSORTIUM TO GAIN MULTI-OMICS-BASED MOLECULAR UNDERSTANDING OF ACUTE KIDNEY INJURY PARTNERSHIP WILL ENABLE EVOTEC TO UNDERSTAND HUMAN DISEASE PROGRESSION ON A MOLECULAR LEVEL AND TO PERFORM TARGETED DRUG DISCOVERY IN FIELD OF AKI Source text: ID:nEQ9ML6XFa Further company coverage: EVTG.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases